https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=5
Versaflex™ TPE delivers an FDA-compliant and soft touch for safety googles gasket
https://www.avient.com/resource-center?document_type=59
Versaflex™ Thermoplastic Elastomers Customized a soft (Shore A) TPE solution that passed strict tests, including thermal deformation (80°C for 2 hours), UV resistance, and assembly resistance
https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=0
Versaflex™ Thermoplastic Elastomers Customized a soft (Shore A) TPE solution that passed strict tests, including thermal deformation (80°C for 2 hours), UV resistance, and assembly resistance
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=11
Study of the effects of formulation and thickness on the dielectric, signal transparency properties of Versaflex TPEs
https://www.avient.com/resource-center?document_subtype=0&document_type=59&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=29
Versaflex™ Thermoplastic Elastomers improved chemical resistance for cosmetic droppers
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=5
Versaflex™ TPE delivers an FDA-compliant and soft touch for safety googles gasket
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=29
Versaflex™ Thermoplastic Elastomers improved chemical resistance for cosmetic droppers
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Requirements:
Soft dampening to protect the
vial and other components
Versaflex™ VDT TPEs
12.
https://www.avient.com/sites/default/files/resources/POL%2520Credit%2520Suisse%2520IR%2520Presentation%2520w%2520non-GAAP%25209%252017%25202013.pdf
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.6
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM for taxes on resin gain
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
EPS: $1.00
$0.54
$0.68
$0.30
$0.45
$0.60
$0.75
H1'12 H1'13
Adjusted EPS
$101.0
$132.6
$50.0
$100.0
$150.0
H1'12 H1'13
Adjusted Operating Income
(millions)
+31%
$68.8
$97.7
$50.0
$75.0
$100.0
H1'12 H1'13
Specialty Operating Income
(millions)
First Half 2013 Financial Highlights
• Adjusted EPS increased 26% over prior
year first half
• Operating Income expanded 31%
versus first half 2012
• Specialty operating income up 42%
• Revenue grew 22% versus 1H ‘12
• Portfolio transformation activities
Completed acquisition of Spartech
Divested non-core Resin business
+26%
+42%
Page 12
• Significant Debt Maturities $ 1,010
Other Debt 21
• Total Debt at 6/30/13
Less: Cash
Net Debt
• Available Liquidity
Cash
ABL Availability
Total Liquidity
• Net Debt / EBITDA = 1.9x*
• Net Debt / EBITDA = 2.1x*(tax adjusted)
$392
310
$702
$1,031
392
$639
$50
$360
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of June 30, 2013
($ millions)
Page 13
Coupon Rates: 7.500% 7.375% 5.250%
*Pro Forma TTM
Debt Maturities & Liquidity Summary – 6/30/13
Cash Balance = $392M
Net Debt / EBITDA* = 1.9x
• Repurchased
~3.0M shares
YTD in 2013
• 17 million shares
are available for
repurchase under
the current
authorization
Share
Repurchase
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Objective of
maintaining and
growing
Dividends
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
Organic
Growth
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
• Synergy opportunities
• Adjacent material solutions
• North American
manufacturing alignment
Acquisitions
*TTM 6/30/2013
Use of Cash
Page 14
Why Invest In PolyOne?